The effect of magnesium in post-CABG arrhythmias

Effect of magnesium in reducing arrhythmias in patients after CABG surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015092224133N1

Enrollment

140

Registered

2015-10-05

Start date

2014-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Ventricular premature depolarization. Condition 2: Atrial fibrillation. Ventricular premature depolarization Atrial fibrillation and flutter

Interventions

Intervention 1: 2 g of magnesium sulfate prescribed in the intervention group before and after surgery, intravenous, single dose. Intervention 2: In the control group administered 2 g of distilled wat

Prevention

Placebo

2 g of magnesium sulfate prescribed in the intervention group before and after surgery, intravenous, single dose

In the control group administered 2 g of distilled water before and after surgery, intravenous, single dose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion :1- All patients candidate elective CABG surgery Cardiac Surgery 2-Primary blood levels of magnesium exclusion : death in the CABG surgery or during the 12 hours after surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cardiac arrhythmia. Timepoint: 3 days after surgery. Method of measurement: Electrocardiogram.	—

Secondary

Measure	Time frame
Blood levels of magnesium. Timepoint: daily for 3 day. Method of measurement: Milligrams per deciliter by arterial blood samples.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarshad Tofighi

Ardabil University of Medical Sciences

researchmed@arums.ac.ir+98 45 3351 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026